Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Response After SARS-CoV-2 Vaccination in a Context of Non-Hodgkin Lymphoma

NCT05050461 is registered in ClinicalTrials.gov with Versailles Hospital as lead sponsor.

NCT NCT05050461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05050461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Response After SARS-CoV-2 Vaccination in a Context of Non-Hodgkin Lymphoma
Lead sponsor
Versailles Hospital
Phase
Not applicable
Overall status
Terminated
Start date
November 15, 2021
Completion date
November 15, 2023
Enrollment
120 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin lymphoma,b cell, vaccination failure